Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders

US11472807B2 · kind B2 · utility

Assignees

• COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR
• PERHA PHARMACEUTICALS · FR

Inventors

• Aloïse Mabondzo · Paris, FR
• Charlotte Leuxe · Paris, FR
• Anne-Cécile Guyot
• Nassima Oumata · Paris, FR
• Laurent Meijer · Morlaix, FR

Key dates

• Filing date: Apr 9, 2018
• Grant date: Oct 18, 2022
• Expiry date: Apr 9, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D473/30
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compound of formula (I) and its addition salts with pharmaceutically acceptable acids, and methods in which an effective amount of the compound or any pharmaceutically acceptable salt thereof is administered (as a medicament) to an individual in need thereof.